Physician profile
Loretta L Lee
NPI 1013973460
$7,727.19
in general payments reported to CMS, 2019-2025
44 companies · $2,262 in 2025
The $2,262 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,176 · 2020: $439 · 2021: $133 · 2022: $363 · 2023: $1,321 · 2024: $2,032 · 2025: $2,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,593 · Education: $23.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,593.33 |
| Education | $23.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,543.07 | 2019-2025 | |
| Novo Nordisk INC | $1,088.49 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $753.03 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $746.64 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $371.95 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Astellas Pharma US INC | $334.22 | 2021-2024 | Veozah |
| Pfizer INC. | $280.69 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $206.27 | 2019-2025 | |
| Exact Sciences Corporation | $178.81 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $178.01 | 2019-2020 | |
| Dexcom, INC. | $163.38 | 2024-2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $141.32 | 2024-2025 | Gemtesa |
| Abbott Laboratories | $123.97 | 2023 | Freestyle Libre 3 |
| Medtronic, INC. | $118.08 | 2022-2025 | Minimed 780g, Venaseal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.22 | 2019-2025 | Xifaxan, Trulance |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loretta Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.